Can Elon Musk’s moonshot deliver the mooted $1.75tn valuation?

You can’t manufacture an IPO, but you can build the conditions that attract and retain the kind of founders who produce them.

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

A significant number of Gen Z workers are bringing their parents into the hiring process, and investor Kevin O'Leary of ...

And does that also apply to betting on what words MrBeast says in his next video?

A significant number of Gen Z workers are bringing their parents into the hiring process, and investor Kevin O'Leary of ...

2026 non-GAAP operating expenses guidance -- $18.0 million to $18.5 million for Q1, with $1.7 million dedicated to IP ...

Canadian securities class actions have grown in size and relevance over the past decade. While the absolute settlement ...

"Winning" for the retiree or the durable income investor is about achieving great and durable income compounding results ...

Morgan Stanley Technology, Media & Telecom Conference 2026 March 2, 2026 3:20 PM ESTCompany ParticipantsSrdjan Tanjga - ...

Foreign investors are returning to China's healthcare sector, but IPO bottlenecks and takeover rules could deter deals, VC ...

The OSC believes it can protect retail private market investors — Tiff Macklem just said monitoring needs improvement ...